To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene USP40TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
339 supporting clones for gene USP40 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AJ583821   .a 1 to 3744 1 to 3744 exact tiling clone,   3744/3744
(100 %)
1 diff
(100.0 %id)
NM_018218.2   .a 1 to 5623 1 to 5623 exact RefSeq,   5623/5623
(100 %)
6 diff
(99.9 %id)
AK001647   .a 39 to 3462 1 to 3424   available from FLJ,   3424/3424
(100 %)
1 diff
(100.0 %id)
AU132741   .a 40 to 880 2 to 844   capped   843/873
(96 %)
13 diff
(98.6 %id)
DA104934 cerebellum .a 103 to 681 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
BF804934 colon_ins .a 150 to 418 271 to 3     Submitted on the opposite strand 269/297
(90 %)
0 diff
(100 %id)
FN076673 breast carcinoma .a 445 to 551 1 to 111       111/111
(100 %)
3 diff
(97.3 %id)
AW752890 colon .a 1341 to 1840 500 to 1       500/500
(100 %)
4 diff
(99.2 %id)
AW752888 colon .a 1358 to 1840 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
BE883410 leiomyosarcoma, uterus .a 1397 to 1718 1 to 327       327/810
(40 %)
8 diff
(99.1 %id)
BF371578 prostate_normal .a 1413 to 1945 549 to 17       533/549
(97 %)
0 diff
(100 %id)
DA449427 tongue, tumor tissue .a 1475 to 2037 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BG749384 eye, normal pigmented retinal epithelium .a 1480 to 2152 1 to 687       687/810
(84 %)
18 diff
(97.8 %id)
DA895178 skeletal muscle .a 1762 to 2312 2 to 555   capped   551/554
(99 %)
3 diff
(99.5 %id)
AW855481 colon .a 1891 to 2018 14 to 141       128/156
(82 %)
8 diff
(94.9 %id)
DN998017 breast cancer, Mammary gland (cancer tissue) .a 2009 to 2592 1 to 584       584/584
(100 %)
5 diff
(99.2 %id)
BE295075 muscle, rhabdomyosarcoma .a 2248 to 2907 1 to 661       661/738
(89 %)
14 diff
(98.2 %id)
CB267727 adipose .a 2346 to 2891 1 to 545       545/545
(100 %)
3 diff
(99.5 %id)
AK295569 hippocampus .a 2429 to 3094 1 to 665       665/1298
(51 %)
2 diff
(99.9 %id)
DC331748 hippocampus .a 2429 to 2987 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
BF736811 bladder_tumor .a 2542 to 2953 415 to 6     Submitted on the opposite strand 410/415
(98 %)
7 diff
(98.4 %id)
AI214561 carcinoid, lung .a 2582 to 2912 1 to 331     Submitted on the opposite strand 331/331
(100 %)
4 diff
(98.8 %id)
BF326332 amnion_normal .a 2627 to 2900 1 to 274       274/284
(96 %)
1 diff
(99.7 %id)
BU076627 Pancreas, Purified pancreatic islet .a 2707 to 3261 1 to 555   fully sequenced,   555/555
(100 %)
0 diff
(100 %id)
BM553538 duodenal adenocarcinoma, cell line, small intestine .a 2756 to 3537 1 to 784       784/1000
(78 %)
11 diff
(98.9 %id)
BF514374   .a 2799 to 3267 18 to 486     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
TI_57191083   .a 2807 to 3470 55 to 720       666/668
(99 %)
4 diff
(99.5 %id)
BI857819 breast, mammary adenocarcinoma, cell line .a 2808 to 3470 1 to 665       665/667
(99 %)
4 diff
(99.5 %id)
BQ712449 Spleen .a 2869 to 3782 1 to 917       917/917
(100 %)
19 diff
(98.0 %id)
BQ708713 Spleen .a 2870 to 3417 18 to 569       552/794
(69 %)
19 diff
(97.7 %id)
BM914346 Spleen .a 2872 to 3430 1 to 560       560/1090
(51 %)
7 diff
(99.4 %id)
BQ709160 Spleen .a 2872 to 3732 1 to 869       869/927
(93 %)
15 diff
(98.4 %id)
BF799756 colon_ins .a 2893 to 3209 27 to 343       317/343
(92 %)
6 diff
(98.3 %id)
AU154214   .a 2934 to 3462 530 to 1       530/530
(100 %)
1 diff
(99.9 %id)
AA583968 larynx .a 2996 to 3432 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
AI023835   .a 3010 to 3466 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AI276469 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3047 to 3456 410 to 1       410/410
(100 %)
1 diff
(99.8 %id)
AW338435 adenocarcinoma, Pancreas .a 3069 to 3462 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AI061230   .a 3076 to 3464 389 to 1       389/389
(100 %)
0 diff
(100 %id)
AI149794   .a 3082 to 3441 402 to 43   AAA   360/380
(94 %)
3 diff
(99.3 %id)
BX099887 pooled germ cell tumors .a 3097 to 3467 380 to 10   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 371/427
(86 %)
3 diff
(99.3 %id)
AW450321   .a 3117 to 3441 362 to 38   AAA   325/351
(92 %)
22 diff
(93.8 %id)
EC449371 Prostate .a 3138 to 3231 1 to 94       94/113
(83 %)
3 diff
(97.4 %id)
EC477668 Prostate .a 3138 to 3247 1 to 109       109/109
(100 %)
2 diff
(98.2 %id)
AI970912 Prostate .a 3154 to 3461 308 to 1       308/308
(100 %)
0 diff
(100 %id)
BF972070 leiomyosarcoma cell line, uterus .a 3170 to 3830 15 to 678       664/1310
(50 %)
21 diff
(98.4 %id)
BG338717 leiomyosarcoma cell line, uterus .a 3170 to 3967 15 to 799       785/799
(98 %)
34 diff
(95.8 %id)
BU076346 Pancreas, Purified pancreatic islet .a 3200 to 3461 262 to 1   fully sequenced,   262/262
(100 %)
3 diff
(98.9 %id)
AA679592   .a 3321 to 3475 158 to 4       155/158
(98 %)
1 diff
(99.4 %id)
BC013305 Muscle, rhabdomyosarcoma .a 3516 to 5609 1 to 2094   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 2094/2094
(100 %)
0 diff
(100 %id)
BE300339 muscle, rhabdomyosarcoma .a 3516 to 4312 24 to 821   available from MGC,   798/827
(96 %)
13 diff
(98.5 %id)
BF205107 muscle, rhabdomyosarcoma .a 3529 to 4280 1 to 744       744/765
(97 %)
14 diff
(98.2 %id)
AK295112 brain .b 1 to 1114 1 to 1116   tiling clone,   1116/1116
(100 %)
3 diff
(99.8 %id)
DA462210 tongue, tumor tissue .b 2 to 491 2 to 491   capped   490/490
(100 %)
1 diff
(99.8 %id)
DB000895 breast, tumor tissue .b 18 to 553 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DA449527 tongue, tumor tissue .b 20 to 583 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA887274   .b 20 to 568 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
CD359558 testis .b 22 to 813 1 to 800   available from MGC,   800/878
(91 %)
10 diff
(98.9 %id)
DA725190   .b 25 to 591 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA754253   .b 25 to 590 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB081859 testis .b 25 to 571 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA034433   .b 26 to 554 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
DA861813 placenta .b 26 to 586 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB213313 trachea .b 26 to 570 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB223978 trachea .b 26 to 585 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB291159 uterus .b 26 to 596 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
CN286175 embryonic stem cells, cell lines H1, H7, andH9 .b 36 to 701 1 to 665       665/665
(100 %)
6 diff
(99.1 %id)
BE784232 eye, retinoblastoma .b 579 to 1252 1 to 673       673/988
(68 %)
13 diff
(98.7 %id)
DA591768 lung .b 947 to 1510 2 to 566   tiling clone, capped   565/565
(100 %)
3 diff
(99.5 %id)
DC356432 heart .b 998 to 1544 1 to 548   tiling clone,   548/548
(100 %)
4 diff
(99.3 %id)
DA499080 brain .b 1092 to 1646 2 to 556   tiling clone, capped   555/555
(100 %)
1 diff
(99.9 %id)
DC362993 Liver .c 1 to 641 1 to 641   tiling clone,   641/641
(100 %)
1 diff
(99.9 %id)
CR624131 Neuroblastoma Cot 25-normalized .c 364 to 1410 1 to 1047   tiling clone,   1047/1047
(100 %)
0 diff
(100 %id)
BX374741 Neuroblastoma Cot 25-normalized .c 364 to 1393 1 to 1023       1023/1023
(100 %)
24 diff
(97.7 %id)
BX350821 Neuroblastoma Cot 25-normalized .c 541 to 1404 871 to 1       868/871
(99 %)
15 diff
(98.3 %id)
BU618998 Cell Line, Chondrosarcoma .c 690 to 1403 729 to 17   AAA   713/714
(99 %)
1 diff
(99.9 %id)
BX369719 Neuroblastoma Cot 25-normalized .c 1084 to 1410 1 to 330       330/330
(100 %)
5 diff
(98.5 %id)
DA493776 brain .c 1184 to 1702 2 to 521   tiling clone, capped   520/520
(100 %)
1 diff
(99.9 %id)
DB315538 brain .c 2474 to 2980 508 to 1   tiling clone,   508/508
(100 %)
7 diff
(98.7 %id)
DA570234 whole embryo, mainly head .d 1 to 726 2 to 725   tiling clone, capped   724/724
(100 %)
5 diff
(99.4 %id)
BF994426 placenta_normal .d 18 to 350 1 to 332       332/351
(94 %)
7 diff
(98.1 %id)
DB356986 whole embryo, mainly head .d 982 to 1577 592 to 1 T2P tiling clone,   592/593
(99 %)
15 diff
(97.5 %id)
AL833371 lymph node .e 1 to 2721 1 to 2721 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 2721/2721
(100 %)
0 diff
(100 %id)
H73443 liver and spleen .e 1740 to 2181 1 to 455       455/465
(97 %)
20 diff
(95.7 %id)
H74202 liver and spleen .e 2377 to 2729 363 to 8       356/442
(80 %)
0 diff
(100 %id)
DR002802 fetal brain .f 1 to 631 2 to 632 exact tiling clone,   632/632
(100 %)
3 diff
(99.6 %id)
DA445985 tongue, tumor tissue .g 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
DB074701 testis .g 50 to 569 2 to 521   capped   520/520
(100 %)
1 diff
(99.9 %id)
AL712528 human skeletal muscle .g 51 to 610 1 to 560       560/560
(100 %)
5 diff
(99.2 %id)
DA220534 brain .g 55 to 614 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA458065 tongue, tumor tissue .g 55 to 638 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
BI598364 brain, hypothalamus .g 56 to 828 1 to 767 K173T E174R C175M K176L N177E ... tiling clone,   767/941
(81 %)
25 diff
(97.4 %id)
DB084951 testis .g 56 to 611 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB196353 trachea .g 56 to 499 2 to 445   capped   444/449
(98 %)
1 diff
(99.8 %id)
DA246623 brain .g 57 to 639 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA461466 tongue, tumor tissue .g 57 to 646 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DA655020   .g 57 to 628 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA740864   .g 59 to 576 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
DB221082 trachea .g 59 to 602 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DC324629 brain .g 61 to 648 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
AL603268 human skeletal muscle .g 61 to 651 1 to 591       591/591
(100 %)
3 diff
(99.5 %id)
TI_45214856   .g 61 to 828 92 to 853 K173T E174R C175M K176L N177E ...     762/1027
(74 %)
25 diff
(97.6 %id)
DA723719   .g 61 to 620 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA459366 tongue, tumor tissue .g 62 to 632 2 to 572   tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
DA724596   .g 62 to 617 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA864858 placenta .g 62 to 616 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA865030 placenta .g 62 to 631 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB005657 breast, tumor tissue .g 62 to 641 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
DB232903 trachea .g 62 to 657 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA451532 tongue, tumor tissue .g 63 to 626 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DB223270 trachea .g 63 to 638 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
DB237757 trachea .g 64 to 644 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA715732   .g 66 to 610 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB078567 testis .g 66 to 619 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA415259 thalamus .g 67 to 617 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA453405 tongue, tumor tissue .g 69 to 628 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA712077   .g 70 to 647 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA457163 tongue, tumor tissue .g 71 to 644 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
TI_57146475   .g 71 to 663 33 to 628       596/905
(65 %)
9 diff
(99.1 %id)
DA988961 synovial membrane tissue from rheumatioidarthritis .g 71 to 640 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
AA127740 uterus .h 1 to 619 612 to 1   tiling clone,   612/627
(97 %)
16 diff
(97.5 %id)
CN482400 eye .h 27 to 665 1 to 639   tiling clone,   639/639
(100 %)
0 diff
(100 %id)
BE784846 large cell carcinoma, lung .h 31 to 623 1 to 591       591/591
(100 %)
7 diff
(98.9 %id)
BE786821 large cell carcinoma, lung .h 81 to 795 1 to 713 Q63R D64T V65C L66C L67* tiling clone,   713/905
(78 %)
43 diff
(95.3 %id)
CR979954 T-Lymphocytes .i 1 to 670 1 to 669 Q150X G163E D164I T165L tiling clone,   669/671
(99 %)
3 diff
(99.6 %id)
AK124094 esophageal, tumor tissue .j 1 to 1945 2 to 1946 exact tiling clone, available from FLJ,   1946/1946
(100 %)
0 diff
(100 %id)
DB017189 esophageal, tumor tissue .j 1 to 574 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA948684 Spleen .j 454 to 1011 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DB335487 esophageal, tumor tissue .j 1414 to 1945 533 to 1       533/533
(100 %)
1 diff
(99.9 %id)
CB958567 Pooled-Glandular .j 1478 to 2208 1 to 736   tiling clone,   736/737
(99 %)
7 diff
(99.1 %id)
BX096463 pooled .j 1483 to 1943 1 to 460   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 460/460
(100 %)
2 diff
(99.6 %id)
AA917073 pooled .j 1635 to 1947 313 to 1       313/313
(100 %)
3 diff
(99.1 %id)
DA456016 tongue, tumor tissue .k -8 to 559 2 to 569 E127V tiling clone, capped   568/568
(100 %)
2 diff
(99.7 %id)
CD655892 Embryonic Stem cells .l 1 to 800 5 to 807 G2P T66A L85A Y86P L88S ... tiling clone,   803/807
(99 %)
15 diff
(98.2 %id)
BM701644 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .m 1 to 299 1 to 299   tiling clone, fully sequenced,   299/299
(100 %)
0 diff
(100 %id)
BU738706 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .m 238 to 625 406 to 19   tiling clone, fully sequenced, AAA   388/388
(100 %)
1 diff
(99.8 %id)
BM704491 eye, Retina Foveal and Macular .n 1 to 348 1 to 348 Q115K tiling clone, fully sequenced,   348/348
(100 %)
3 diff
(99.2 %id)
BU736662 eye, Retina Foveal and Macular .n 67 to 347 282 to 1   fully sequenced,   282/282
(100 %)
3 diff
(99.0 %id)
AW863694 stomach_normal .o 1 to 431 430 to 2   tiling clone,   429/434
(98 %)
0 diff
(100 %id)
BE645412 Prostate .o 291 to 634 344 to 1 exact tiling clone,   344/344
(100 %)
0 diff
(100 %id)
AI921324 adenocarcinoma, Pancreas .p 1 to 453 460 to 8 exact tiling clone,   453/460
(98 %)
0 diff
(100 %id)
DA715916   .q-u 1 to 538 2 to 539   tiling clone, capped   538/538
(100 %)
1 diff
(99.9 %id)
AA377983 synovial membrane .q-u 359 to 621 1 to 263   tiling clone,   263/263
(100 %)
0 diff
(100 %id)
AL120598 amygdala .q-u 1350 to 1889 1 to 541   tiling clone,   541/541
(100 %)
2 diff
(99.7 %id)
CF265115 Brain glioblastoma .q-u 1473 to 2059 1 to 589       589/784
(75 %)
12 diff
(98.5 %id)
BE145775 head_neck .q-u 1633 to 1835 1 to 203       203/203
(100 %)
1 diff
(99.6 %id)
BG326507 Kidney, renal cell adenocarcinoma .q-u 1649 to 2191 120 to 661       542/662
(81 %)
5 diff
(99.3 %id)
BY795322 eye .q-u 1663 to 2248 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BP425888 small intestine .q-u 1684 to 2040 360 to 1       360/360
(100 %)
5 diff
(98.7 %id)
CV574568 cornea, eye .q-u 1686 to 2057 1 to 372       372/372
(100 %)
2 diff
(99.5 %id)
BG489962 large cell carcinoma, lung .q-u 1724 to 2386 1 to 663       663/663
(100 %)
0 diff
(100 %id)
FN057606 breast carcinoma .q-u 1734 to 1819 86 to 1     Submitted on the opposite strand 86/88
(97 %)
0 diff
(100 %id)
CR594906 Neuroblastoma Cot 25-normalized .q-u 1795 to 3270 1 to 1476   tiling clone,   1476/1476
(100 %)
0 diff
(100 %id)
BX331970 Neuroblastoma Cot 25-normalized .q-u 1795 to 2656 1 to 861       861/861
(100 %)
16 diff
(98.2 %id)
BM682382 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q-u 1864 to 2511 1 to 647     Submitted on the opposite strand 647/647
(100 %)
3 diff
(99.6 %id)
BQ001269 lung, Metastatic Chondrosarcoma .q-u 1865 to 2602 1 to 738     Submitted on the opposite strand 738/740
(99 %)
7 diff
(99.1 %id)
BC047714 Testis, embryonal carcinoma .q-u 1868 to 3456 1622 to 34   available from MGC, AAA Submitted on the opposite strand 1589/1591
(99 %)
2 diff
(99.9 %id)
BQ286147 Pancreas, Purified pancreatic islet .q-u 1878 to 2404 1 to 527     Submitted on the opposite strand 527/527
(100 %)
1 diff
(99.9 %id)
AI681267 carcinoid, lung .q-u 1882 to 2372 1 to 491     Submitted on the opposite strand 491/491
(100 %)
2 diff
(99.6 %id)
AI813470 2 pooled tumors (clear cell type), Kidney .q-u 1882 to 2288 1 to 406     Submitted on the opposite strand 406/406
(100 %)
3 diff
(99.3 %id)
AW002292 thymus, pooled .q-u 1882 to 2270 1 to 388     Submitted on the opposite strand 388/388
(100 %)
1 diff
(99.8 %id)
CB241030 Human Lung Epithelial cells, lung .q-u 1886 to 2583 713 to 16   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 698/698
(100 %)
2 diff
(99.8 %id)
BF304494 muscle, rhabdomyosarcoma .q-u 1892 to 2562 1 to 663       663/795
(83 %)
7 diff
(99.2 %id)
BF304596 muscle, rhabdomyosarcoma .q-u 1892 to 2615 1 to 724       724/726
(99 %)
12 diff
(98.4 %id)
BE297277 muscle, rhabdomyosarcoma .q-u 1913 to 2454 1 to 542       542/542
(100 %)
0 diff
(100 %id)
CK825765 Pancreas, Purified pancreatic islet .q-u 1941 to 2304 1 to 364       364/364
(100 %)
3 diff
(99.2 %id)
DB324162   .q-u 1954 to 2486 533 to 1       533/535
(99 %)
1 diff
(99.9 %id)
BG753502 eye, normal pigmented retinal epithelium .q-u 1973 to 2620 1 to 648       648/648
(100 %)
4 diff
(99.4 %id)
BU956432 adenocarcinoma, cell line, breast .q-u 2065 to 2902 1 to 844       844/877
(96 %)
7 diff
(99.3 %id)
CV802683 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .q-u 2081 to 2814 1 to 726       726/829
(87 %)
12 diff
(98.6 %id)
BG679666 skin, squamous cell carcinoma .q-u 2152 to 2999 1 to 844       844/849
(99 %)
7 diff
(99.2 %id)
BP432269   .q-u 2172 to 2536 1 to 365       365/365
(100 %)
0 diff
(100 %id)
AI818342 adenocarcinoma, Pancreas .q-u 2244 to 2369 1 to 126     Submitted on the opposite strand 126/126
(100 %)
0 diff
(100 %id)
BG824115 adenocarcinoma cell line, colon .q-u 2254 to 2884 1 to 636       636/638
(99 %)
8 diff
(98.8 %id)
AW882372 ovary .q-u 2272 to 2568 304 to 8       297/313
(94 %)
0 diff
(100 %id)
CR993767 T-Lymphocytes .q-u 2327 to 3165 1 to 839       839/842
(99 %)
3 diff
(99.7 %id)
BQ935229 brain, neuroblastoma, cell line .q-u 2354 to 3285 1 to 937       937/941
(99 %)
27 diff
(97.2 %id)
AW392704 stomach .q-u 2400 to 2955 555 to 1       555/557
(99 %)
8 diff
(98.6 %id)
BM844730 lymph node, stomach .q-u 2469 to 2944 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
BX103809 liver and spleen .q-u 2475 to 3178 1 to 704       704/704
(100 %)
0 diff
(100 %id)
TI_159709882   .q-u 2476 to 3456 1040 to 82   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 959/995
(96 %)
30 diff
(97.0 %id)
BX389423 Neuroblastoma Cot 25-normalized .q-u 2481 to 3265 1 to 792       792/798
(99 %)
15 diff
(98.2 %id)
AA382905 testis .q-u 2493 to 2799 1 to 312       312/316
(98 %)
7 diff
(97.8 %id)
AW956738   .q-u 2493 to 3103 1 to 612       612/623
(98 %)
11 diff
(98.3 %id)
BM721322 eye, fetal eye .q-u 2497 to 2991 1 to 495   fully sequenced, Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 495/495
(100 %)
1 diff
(99.8 %id)
AA256400 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 2513 to 2989 1 to 476       476/476
(100 %)
1 diff
(99.8 %id)
CB145661 Liver .q-u 2514 to 2946 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
AA233103 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 2530 to 2995 1 to 464   fully sequenced,   464/464
(100 %)
4 diff
(99.2 %id)
BM693755 eye, lens .q-u 2534 to 3006 1 to 473   fully sequenced, Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 473/473
(100 %)
0 diff
(100 %id)
AA418436 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 2546 to 3125 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BX350863 Neuroblastoma Cot 25-normalized .q-u 2551 to 3452 912 to 1       912/912
(100 %)
48 diff
(94.8 %id)
AV692970 hepatocellular carcinoma .q-u 2552 to 3213 1 to 662       662/670
(98 %)
7 diff
(99.0 %id)
AV694056 hepatocellular carcinoma .q-u 2552 to 3213 1 to 662       662/669
(98 %)
9 diff
(98.7 %id)
EL954838 eyeball .q-u 2553 to 3073 55 to 570       516/570
(90 %)
6 diff
(99.0 %id)
H01723 placenta .q-u 2555 to 2846 1 to 297       297/306
(97 %)
7 diff
(97.8 %id)
AW968476   .q-u 2577 to 3086 1 to 510       510/510
(100 %)
9 diff
(98.3 %id)
AA459489 germinal center B cell .q-u 2577 to 3053 1 to 476   fully sequenced,   476/476
(100 %)
1 diff
(99.8 %id)
BE745208 adenocarcinoma cell line, ovary .q-u 2591 to 3253 1 to 666       666/666
(100 %)
7 diff
(99.0 %id)
BC086855 Chondrosarcoma, Left Pubic Bone, Lung, chondrosarcoma lung metastasis .q-u 2607 to 3456 1 to 850   fully sequenced, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 850/850
(100 %)
1 diff
(99.9 %id)
T79712 liver and spleen .q-u 2609 to 2933 1 to 337       337/370
(91 %)
20 diff
(94.6 %id)
CB054286 brain, glioblastoma (pooled) .q-u 2612 to 2933 3 to 324   fully sequenced, Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 322/324
(99 %)
5 diff
(98.5 %id)
BI063184 uterus_tumor .q-u 2641 to 2914 274 to 1       274/274
(100 %)
2 diff
(99.3 %id)
TI_154102167   .q-u 2653 to 3462 877 to 78   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 800/981
(81 %)
17 diff
(98.3 %id)
BE840588 prostate_normal .q-u 2664 to 2942 305 to 29       277/311
(89 %)
0 diff
(100 %id)
TI_149285337   .q-u 2670 to 3456 866 to 84   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 783/820
(95 %)
12 diff
(98.6 %id)
BF811686 colon_ins .q-u 2680 to 3041 372 to 11     Submitted on the opposite strand 362/372
(97 %)
0 diff
(100 %id)
BE387701 endometrium, adenocarcinoma cell line, uterus .q-u 2704 to 3359 1 to 650       650/734
(88 %)
9 diff
(98.8 %id)
BM693828 eye, lens .q-u 2714 to 3062 1 to 349   fully sequenced, Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 349/349
(100 %)
2 diff
(99.5 %id)
CA428035 Bone, Subchondral Bone .q-u 2730 to 3456 744 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 726/726
(100 %)
2 diff
(99.8 %id)
BF811401 colon_ins .q-u 2743 to 3041 328 to 30     Submitted on the opposite strand 299/328
(91 %)
0 diff
(100 %id)
CU449532 epidermis .q-u 2751 to 3036 19 to 305       287/307
(93 %)
10 diff
(96.8 %id)
CU450705 epidermis .q-u 2751 to 3036 19 to 304       286/327
(87 %)
5 diff
(98.5 %id)
CU455114 epidermis .q-u 2751 to 3036 19 to 304       286/357
(80 %)
5 diff
(98.6 %id)
TI_149278539   .q-u 2758 to 3456 760 to 62   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 699/700
(99 %)
1 diff
(99.9 %id)
BU678509 lung, Primary Lung Epithelial Cells .q-u 2778 to 3456 697 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 679/679
(100 %)
1 diff
(99.9 %id)
BE693576 breast .q-u 2811 to 3175 1 to 364       364/364
(100 %)
6 diff
(98.4 %id)
AW361308 colon .q-u 2818 to 3175 11 to 368       358/368
(97 %)
6 diff
(98.4 %id)
BQ347672 head_neck .q-u 2821 to 3185 19 to 388       370/394
(93 %)
7 diff
(98.3 %id)
AW361346 colon .q-u 2829 to 3111 283 to 1       283/283
(100 %)
14 diff
(95.1 %id)
AW368549 head_neck .q-u 2829 to 3175 347 to 1       347/347
(100 %)
5 diff
(98.6 %id)
AW368583 head_neck .q-u 2829 to 3185 363 to 4       360/363
(99 %)
0 diff
(100 %id)
AW377759 head_neck .q-u 2829 to 3112 1 to 284       284/284
(100 %)
1 diff
(99.7 %id)
AW854377 colon .q-u 2829 to 3185 367 to 11       357/367
(97 %)
0 diff
(100 %id)
CB157786 Liver .q-u 2830 to 3035 206 to 1     Submitted on the opposite strand 206/206
(100 %)
0 diff
(100 %id)
BM984857 lung .q-u 2841 to 3456 634 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 616/616
(100 %)
0 diff
(100 %id)
BE927263 colon .q-u 2842 to 3175 1 to 334       334/334
(100 %)
13 diff
(96.2 %id)
AW368598 head_neck .q-u 2848 to 3190 1 to 346       346/349
(99 %)
11 diff
(96.9 %id)
CA445398 Chondrosarcoma, Left Pubic Bone .q-u 2848 to 3462 634 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 616/616
(100 %)
1 diff
(99.9 %id)
CA413260 Chondrosarcoma Grade II, Left Pelvis .q-u 2849 to 3456 626 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 608/608
(100 %)
0 diff
(100 %id)
BQ771950 Chondrosarcoma Grade II, Left Pelvis .q-u 2849 to 3456 626 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 608/608
(100 %)
0 diff
(100 %id)
AW368597 head_neck .q-u 2851 to 3175 1 to 325       325/325
(100 %)
7 diff
(97.9 %id)
BM694132 eye, RPE and Choroid .q-u 2851 to 3210 1 to 360   fully sequenced, Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 360/360
(100 %)
0 diff
(100 %id)
BQ026242 placenta .q-u 2854 to 3456 621 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 603/603
(100 %)
0 diff
(100 %id)
CK825764 Pancreas, Purified pancreatic islet .q-u 2857 to 3446 590 to 1       590/590
(100 %)
0 diff
(100 %id)
BU626281 Bone, Subchondral Bone .q-u 2865 to 3456 611 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 593/593
(100 %)
1 diff
(99.9 %id)
AA889334   .q-u 2873 to 3403 530 to 1       530/530
(100 %)
8 diff
(98.5 %id)
AA522888 lung, lung tumor .q-u 2875 to 3455 582 to 1       582/582
(100 %)
6 diff
(99.0 %id)
AW361350 colon .q-u 2877 to 3175 1 to 299       299/299
(100 %)
10 diff
(96.7 %id)
CD370031 Alveolar Macrophage, lung .q-u 2882 to 3456 593 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 575/575
(100 %)
0 diff
(100 %id)
AI924760 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .q-u 2886 to 3455 570 to 1       570/570
(100 %)
2 diff
(99.7 %id)
N98612 senescent fibroblast .q-u 2897 to 3457 573 to 8       566/573
(98 %)
0 diff
(100 %id)
BF349706 head_neck .q-u 2899 to 3168 277 to 8       270/277
(97 %)
0 diff
(100 %id)
CB054285 brain, glioblastoma (pooled) .q-u 2903 to 3456 604 to 51   fully sequenced, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 554/554
(100 %)
3 diff
(99.5 %id)
CV415637 colon .q-u 2909 to 3114 1 to 212       212/214
(99 %)
16 diff
(92.6 %id)
TI_57234691   .q-u 2914 to 3430 33 to 552       520/715
(72 %)
7 diff
(99.1 %id)
BI908846 leukocyte .q-u 2915 to 3430 1 to 519       519/602
(86 %)
7 diff
(98.9 %id)
AW361329 colon .q-u 2917 to 3185 1 to 270       270/276
(97 %)
10 diff
(96.4 %id)
AW377755 head_neck .q-u 2919 to 3183 268 to 4       265/268
(98 %)
0 diff
(100 %id)
AW166134 brain, medulloblastoma .q-u 2926 to 3457 533 to 2       532/533
(99 %)
0 diff
(100 %id)
BU754477 placenta .q-u 2931 to 3456 544 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 526/526
(100 %)
0 diff
(100 %id)
BF743341 breast .q-u 2946 to 3385 441 to 2     Submitted on the opposite strand 440/441
(99 %)
0 diff
(100 %id)
BM677061 eye, fetal eye .q-u 2961 to 3456 514 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 496/496
(100 %)
1 diff
(99.8 %id)
W20007 parathyroid gland, parathyroid tumor .q-u 2962 to 3286 1 to 338   fully sequenced,   338/338
(100 %)
11 diff
(96.8 %id)
AW974006   .q-u 2966 to 3455 489 to 1     Submitted on the opposite strand 489/489
(100 %)
3 diff
(99.4 %id)
BQ269509 Pancreas, Purified pancreatic islet .q-u 2968 to 3454 514 to 28     Submitted on the opposite strand 487/514
(94 %)
0 diff
(100 %id)
AW753308 colon .q-u 2971 to 3185 1 to 217       217/220
(98 %)
12 diff
(94.6 %id)
AA243662 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 2973 to 3400 427 to 1   fully sequenced,   427/427
(100 %)
6 diff
(98.6 %id)
BU738195 eye, lens .q-u 2976 to 3463 506 to 19 exact fully sequenced, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 488/488
(100 %)
0 diff
(100 %id)
AI814414 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .q-u 2986 to 3456 481 to 11   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 471/471
(100 %)
1 diff
(99.8 %id)
BF434147 fibrotheoma, ovary .q-u 2993 to 3423 431 to 1       431/431
(100 %)
9 diff
(98.0 %id)
BM801120 embryonal carcinoma, cell line, testis .q-u 2993 to 3456 496 to 33   available from MGC, AAA Submitted on the opposite strand 464/1110
(41 %)
3 diff
(99.8 %id)
AA834124 Kidney, kidney tumor .q-u 2995 to 3457 463 to 2       462/463
(99 %)
0 diff
(100 %id)
AA700524 parathyroid gland, parathyroid tumor .q-u 2996 to 3457 465 to 6       460/465
(98 %)
0 diff
(100 %id)
AA609418   .q-u 2996 to 3457 464 to 3       462/464
(99 %)
0 diff
(100 %id)
AA827220 germinal center B cell .q-u 2996 to 3455 467 to 11   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 457/457
(100 %)
9 diff
(98.1 %id)
AW517683 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .q-u 2996 to 3456 472 to 12   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 461/461
(100 %)
0 diff
(100 %id)
CB145961 Liver .q-u 2996 to 3456 484 to 24   AAA Submitted on the opposite strand 461/461
(100 %)
6 diff
(98.7 %id)
AW629299 pooled .q-u 2997 to 3457 463 to 3       461/463
(99 %)
0 diff
(100 %id)
AA837159 germinal center B cell .q-u 2999 to 3455 466 to 11   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 456/456
(100 %)
6 diff
(98.7 %id)
AI168665 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 3002 to 3457 456 to 4       453/456
(99 %)
0 diff
(100 %id)
AA833958 Kidney, kidney tumor .q-u 3004 to 3457 455 to 3       453/455
(99 %)
0 diff
(100 %id)
AI277615 placenta .q-u 3008 to 3464 463 to 7 exact tiling clone,   457/463
(98 %)
0 diff
(100 %id)
AI926689 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .q-u 3008 to 3457 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI803502 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 3009 to 3456 462 to 15   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 448/448
(100 %)
1 diff
(99.8 %id)
AW368577 head_neck .q-u 3016 to 3185 185 to 11       175/185
(94 %)
0 diff
(100 %id)
AI421404 brain, glioblastoma (pooled) .q-u 3018 to 3457 441 to 2       440/441
(99 %)
0 diff
(100 %id)
AI139008   .q-u 3019 to 3457 444 to 8       437/444
(98 %)
0 diff
(100 %id)
BM670891 eye, lens .q-u 3032 to 3456 443 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 425/425
(100 %)
1 diff
(99.8 %id)
AW166510 cervix .q-u 3037 to 3457 423 to 3       421/423
(99 %)
0 diff
(100 %id)
BM673123 eye, optic nerve .q-u 3043 to 3456 432 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
AI183341 heart .q-u 3044 to 3456 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AW080392 esophagus, squamous cell carcinoma .q-u 3045 to 3456 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AA694170 liver and spleen .q-u 3046 to 3456 410 to 1       410/410
(100 %)
3 diff
(99.3 %id)
AA459261 germinal center B cell .q-u 3047 to 3455 410 to 2   fully sequenced,   409/410
(99 %)
0 diff
(100 %id)
BQ022772 placenta .q-u 3052 to 3456 423 to 19   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 405/405
(100 %)
0 diff
(100 %id)
AI285658 esophagus, squamous cell carcinoma .q-u 3058 to 3456 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AW572638 lymph node, lymphoma, follicular mixed small and largecell .q-u 3061 to 3450 390 to 1       390/390
(100 %)
0 diff
(100 %id)
BE857367 brain, glioblastoma (pooled) .q-u 3074 to 3454 410 to 30   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 381/381
(100 %)
4 diff
(99.0 %id)
AA463705 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 3079 to 3456 377 to 1       377/377
(100 %)
2 diff
(99.5 %id)
BF940604 fibrotheoma, ovary .q-u 3086 to 3454 381 to 13   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 369/369
(100 %)
0 diff
(100 %id)
T79627 liver and spleen .q-u 3087 to 3457 380 to 2       379/400
(94 %)
0 diff
(100 %id)
N68044 cochlea, ear .q-u 3089 to 3456 373 to 1       373/417
(89 %)
12 diff
(97.2 %id)
AI022189 liver and spleen .q-u 3091 to 3457 368 to 2       367/368
(99 %)
0 diff
(100 %id)
AI218147 pooled .q-u 3091 to 3456 382 to 17   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 366/366
(100 %)
0 diff
(100 %id)
BQ022170 placenta .q-u 3095 to 3456 379 to 18   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 362/362
(100 %)
1 diff
(99.8 %id)
AI042467 senescent fibroblast .q-u 3100 to 3457 364 to 7       358/364
(98 %)
0 diff
(100 %id)
AA256294 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 3102 to 3456 355 to 1       355/355
(100 %)
5 diff
(98.6 %id)
BQ013992 Chondrosarcoma, Left Pubic Bone, Lung, chondrosarcoma lung metastasis .q-u 3103 to 3456 372 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 354/354
(100 %)
0 diff
(100 %id)
BQ304505 breast .q-u 3109 to 3212 106 to 3       104/106
(98 %)
0 diff
(100 %id)
AI138996   .q-u 3110 to 3457 350 to 3       348/350
(99 %)
0 diff
(100 %id)
H00982 placenta .q-u 3112 to 3428 331 to 1       331/385
(85 %)
17 diff
(95.6 %id)
AI375976   .q-u 3112 to 3464 359 to 7 exact     353/359
(98 %)
0 diff
(100 %id)
AW183567 pooled .q-u 3115 to 3457 347 to 5       343/347
(98 %)
0 diff
(100 %id)
AI140576 liver and spleen .q-u 3121 to 3456 335 to 1       335/335
(100 %)
5 diff
(98.6 %id)
AA779576   .q-u 3132 to 3464 338 to 7 P39R G40A R41G P42L V43C ...     332/348
(95 %)
0 diff
(100 %id)
AI381413   .q-u 3135 to 3457 328 to 5       324/328
(98 %)
0 diff
(100 %id)
AA878685 2 pooled tumors (clear cell type), Kidney .q-u 3140 to 3400 265 to 5       261/265
(98 %)
0 diff
(100 %id)
BQ304504 breast .q-u 3145 to 3300 159 to 3       157/159
(98 %)
0 diff
(100 %id)
AI092382 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q-u 3152 to 3456 303 to 1       303/303
(100 %)
2 diff
(99.4 %id)
AA813029   .q-u 3153 to 3457 306 to 3       304/306
(99 %)
0 diff
(100 %id)
AA987855 Kidney, kidney tumor .q-u 3153 to 3464 312 to 2 R35W V37X R38A P39R G40A ...     311/312
(99 %)
0 diff
(100 %id)
BU732310 eye, RPE and Choroid .q-u 3180 to 3456 295 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 277/277
(100 %)
0 diff
(100 %id)
AI702339 adenocarcinoma, Pancreas .q-u 3201 to 3457 259 to 1       259/259
(100 %)
2 diff
(99.3 %id)
AI392789 B-cell, chronic lymphotic leukemia .q-u 3216 to 3463 248 to 1       248/248
(100 %)
0 diff
(100 %id)
N91348 parathyroid gland, parathyroid tumor .q-u 3256 to 3456 201 to 1   fully sequenced,   201/201
(100 %)
3 diff
(98.6 %id)
AA558929 breast .q-u 3257 to 3456 210 to 11   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 200/200
(100 %)
5 diff
(97.5 %id)
AA557439 low-grade prostatic neoplasia, Prostate .q-u 3263 to 3447 205 to 21   AAA   185/194
(95 %)
0 diff
(100 %id)
AA770052 liver and spleen .q-u 3269 to 3457 190 to 2       189/190
(99 %)
0 diff
(100 %id)
AW073159 brain, glioblastoma (pooled) .q-u 3269 to 3454 194 to 9       186/194
(95 %)
0 diff
(100 %id)
FN116260 breast carcinoma .q-u 3271 to 3381 1 to 112       112/112
(100 %)
3 diff
(97.4 %id)
AI699717 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .q-u 3290 to 3456 167 to 1       167/167
(100 %)
1 diff
(99.5 %id)
AA884336 pooled .q-u 3330 to 3456 143 to 17   AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 127/127
(100 %)
0 diff
(100 %id)
AA470400 colon .q-u 3339 to 3428 89 to 1       89/89
(100 %)
2 diff
(97.8 %id)
AI193808 lung .q-u 3358 to 3455 98 to 1       98/98
(100 %)
1 diff
(99.0 %id)
AA705996 parathyroid gland, parathyroid tumor .q-u 3377 to 3457 86 to 6       81/86
(94 %)
0 diff
(100 %id)
BU852158 testis .r-u 1 to 530 1 to 530   tiling clone,   530/533
(99 %)
3 diff
(99.5 %id)
BG402127 Kidney .r-u 109 to 817 1 to 702   tiling clone,   702/863
(81 %)
20 diff
(97.7 %id)
BG565705 Liver .r-u 367 to 1022 1 to 662   tiling clone,   662/667
(99 %)
11 diff
(98.4 %id)
BE048512 Kidney .r-u 525 to 941 424 to 7   tiling clone,   418/424
(98 %)
0 diff
(100 %id)
AL601395   .r-u 926 to 1402 1 to 485   tiling clone, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 485/485
(100 %)
5 diff
(99.0 %id)
DN919447   .r-u 1348 to 1969 1 to 618   tiling clone,   618/619
(99 %)
9 diff
(98.6 %id)
CR611364 fetal brain .s-u 1 to 1218 1 to 1218 exact tiling clone,   1218/1218
(100 %)
0 diff
(100 %id)
AL538879 brain, fetal brain .s-u 1 to 869 1 to 869 C2X S44T H45L C46X A47L ...     869/869
(100 %)
14 diff
(98.4 %id)
N25507 melanocyte .s-u 252 to 596 87 to 435       349/438
(79 %)
10 diff
(97.8 %id)
AL567538 brain, fetal brain .s-u 267 to 1171 907 to 1       907/907
(100 %)
9 diff
(99.1 %id)
CV381271 uterus_tumor .s-u 275 to 619 78 to 414       337/414
(81 %)
6 diff
(98.6 %id)
BX451679 brain, fetal brain .s-u 740 to 1218 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
H29210 whole brain .t-u 1 to 477 1 to 479 E67D L68* tiling clone,   479/479
(100 %)
4 diff
(99.2 %id)
BX094198 whole brain .t-u 492 to 1052 563 to 1   tiling clone, Submitted on the opposite strand 563/563
(100 %)
3 diff
(99.5 %id)
CA395789 eye, RPE/choroid .t-u 502 to 1086 1 to 585   tiling clone,   585/585
(100 %)
1 diff
(99.9 %id)
H29211 whole brain .t-u 550 to 1047 500 to 1       500/505
(99 %)
14 diff
(97.3 %id)
AA701532 liver and spleen .t-u 568 to 1038 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
AA348684 brain, hippocampus .t-u 735 to 1038 304 to 1     Submitted on the opposite strand 304/304
(100 %)
1 diff
(99.7 %id)
DA713959   .u 1 to 567 2 to 569 exact tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
DB216945 trachea .va-u 1 to 554 2 to 554 R9K T11L L12* tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
AA174136.
matches multiple genes
  .vb-u 1 to 542 540 to 1 exact tiling clone, also hits gene gladoyby 540/540
(100 %)
18 diff
(96.7 %id)
DB217745 trachea .vc-u 1 to 489 2 to 490 exact tiling clone, capped   489/489
(100 %)
1 diff
(99.8 %id)
DW443012 Liver .vd 1 to 179 6 to 184 exact tiling clone, AAA Possibly primed on the genome, locally A rich (31/34 A in genome downstream of last aligned base) 179/184
(97 %)
6 diff
(96.8 %id)
FN054843 breast carcinoma .ve-u 1 to 67 1 to 67 D9G tiling clone,   67/67
(100 %)
2 diff
(97.1 %id)
AV702381 adrenal gland Gene USP40, variant not shown         Suspected internal deletion, this clone was ignored    
AK297821 heart Gene USP40, variant not shown         This clone was ignored    
CU442889 epidermis Gene USP40, variant not shown         This clone was ignored    
CU444681 epidermis Gene USP40, variant not shown         This clone was ignored    
CU445693 epidermis Gene USP40, variant not shown         This clone was ignored    
CU449001 epidermis Gene USP40, variant not shown         This clone was ignored    
CU449722 epidermis Gene USP40, variant not shown         This clone was ignored    
CU453104 epidermis Gene USP40, variant not shown         This clone was ignored    
T58221 fetal spleen, Spleen Gene USP40, variant not shown         This clone was ignored    
AA043738 uterus Gene USP40, variant not shown         Suspected internal deletion, this clone was ignored    
AA043739 uterus Gene USP40, variant not shown         Suspected internal deletion, this clone was ignored    
BC067300 testis Gene USP40, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
TI_154120403   Gene USP40, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u, .r-u, .s-u, .t-u, .u, .va-u, .vb-u, .vc-u, .vd, .ve-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI